Salvage treatment of disseminated strongyloidiasis in an immunocompromised patient: therapy success with subcutaneous ivermectin
Braz. j. infect. dis
;
16(5): 479-481, Sept.-Oct. 2012. ilus
Article
in English
| LILACS
| ID: lil-653437
ABSTRACT
Disseminated strongyloidiasis is a disease with high mortality rate, especially in immunocompromised individuals. Paralytic ileus and intestinal malabsorption are frequent symptoms caused by this severe disease. As there are no licensed parenteral anthelmintic drugs for human use, off-label formulations are often used in the treatment of this disease. In this case report, the use of subcutaneous ivermectin is described as a successful therapy for this life-threatening infection.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Strongyloidiasis
/
Ivermectin
/
Antiparasitic Agents
Type of study:
Diagnostic study
Limits:
Animals
/
Humans
/
Male
Language:
English
Journal:
Braz. j. infect. dis
Journal subject:
Communicable Diseases
Year:
2012
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Hospital Santa Luzia/BR
Similar
MEDLINE
...
LILACS
LIS